Free Trial

Marinus Pharmaceuticals (MRNS) SEC Filings & 10K Form

Marinus Pharmaceuticals logo
$0.31 0.00 (0.00%)
(As of 11/20/2024 ET)

Recent Marinus Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
9:35 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
11/15/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:39 PM
Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
Form SC 13G
11/14/2024
2:04 PM
Cormorant Asset Management, LP (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
11:24 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
8:34 AM
Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
8:55 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/01/2024
7:30 PM
Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13G
10/31/2024
12:05 PM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
10/24/2024
7:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
6:57 AM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:56 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:15 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:09 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:20 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:22 PM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:23 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:23 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:01 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:55 PM
Marinus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2024
5:35 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:07 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
4:51 PM
CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
04/19/2024
5:04 AM
Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
04/15/2024
6:32 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
04/04/2024
7:02 AM
Marinus Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
10:55 AM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
11:18 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
9:35 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G
02/14/2024
8:04 AM
Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
11:13 AM
Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/08/2024
12:56 PM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
02/07/2024
6:25 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2024
10:58 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
01/19/2024
3:18 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:19 PM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:20 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:21 PM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:21 PM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:22 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:23 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:23 PM
Marinus Pharmaceuticals (Issuer)
Nochur Sara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:25 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:26 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:27 PM
Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:28 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
6:04 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners